Tropical diseases prevalent in leprosy-endemic areas may alter the immunological patient response and also complicate the presentation of leprosy reactional episodes. The introduction of anti-malarial drugs in our case produced a subsidence of reaction. With dwindling manpower skilled in leprosy, the reactional episodes are very often treated with non-steroidal anti-inflammatory drugs, steroids and thalidomide, neglecting the possibility of other co-existing infections, tropical or other. Our case emphasises the importance of history, examination and balanced investigation in the context of tropical diseases in endemic areas before injudicious intervention.
NarangTAlmeidaJGKumarB, et al.Fixed duration multidrug therapy (12 months) in leprosy patients with high bacillary load—need to look beyond. Indian J Dermatol Venereol Leprol2023 Jul 21: 1–4. doi: 10.25259/IJDVL_278_2023
2.
JeeyapantAKingstonHWPlewesK, et al.Defining surrogate endpoints for clinical trials in severe falciparum malaria. PLoS One2017; 12: e0169307.
3.
WarrellDALooareesuwanSWarrellMJ, et al.Dexamethasone proves deleterious in cerebral malaria: a double-blind trial in 100 comatose patients. N Engl J Med1982; 306: 313–319.
4.
World Health Organization. WHO guidelines for malaria, 14 March 2023 (No. WHO/UCN/GMP/2023.01). World Health Organization. 2023.
5.
Guidelines for Diagnosis and Treatment of Malaria in India. 3rd ed. New Delhi: National Institute of Malaria Research, New Delhi; 2014. https://nvbdcp.gov.in/WriteReadData/l892 s/20627628441542176662.pdf.
6.
World Health Organization. Report of informal consultation on treatment of reactions and prevention of disabilities, 11-13 December 2018, Chennai, India (No. SEA-GLP-2019.1). World Health Organization. Regional Office for South-East Asia. 2019.
